Do analysts prefer PMNT or SILO?

Perfect Moment presently has a consensus target price of $1.50, indicating a potential upside of 757.14%. Given Perfect Moment's stronger consensus rating and higher possible upside, equities research analysts clearly believe Perfect Moment is more favorable than Silo Pharma. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Perfect Moment 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Silo Pharma 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is PMNT or SILO more profitable?

Perfect Moment has a net margin of -67.38% compared to Silo Pharma's net margin of -6,726.39%. Silo Pharma's return on equity of -88.40% beat Perfect Moment's return on equity. Company Net Margins Return on Equity Return on Assets Perfect Moment -67.38% -513.83% -119.38% Silo Pharma -6,726.39% -88.40% -70.03%

Do analysts rate EVKG or SILO?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ever-Glory International Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Silo Pharma 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable valuation and earnings, EVKG or SILO?

Ever-Glory International Group has higher earnings, but lower revenue than Silo Pharma. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Ever-Glory International Group N/A N/A N/A N/A N/A Silo Pharma $72.10K 82.96 -$4.23M -$6.45 N/A

Do analysts prefer ONON or SILO?

ON presently has a consensus target price of $55.05, indicating a potential upside of 42.39%. Given ON's stronger consensus rating and higher possible upside, equities research analysts plainly believe ON is more favorable than Silo Pharma. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ON 1 Sell rating(s) 4 Hold rating(s) 15 Buy rating(s) 2 Strong Buy rating(s) 2.82 Silo Pharma 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better earnings & valuation, ONON or SILO?

ON has higher revenue and earnings than Silo Pharma. Silo Pharma is trading at a lower price-to-earnings ratio than ON, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio ON $3.64B 6.78 $245.87M $0.93 41.57 Silo Pharma $72.10K 82.96 -$4.23M -$6.45 N/A

Is ONON or SILO more profitable?

ON has a net margin of 7.92% compared to Silo Pharma's net margin of -6,726.39%. ON's return on equity of 15.72% beat Silo Pharma's return on equity. Company Net Margins Return on Equity Return on Assets ON 7.92% 15.72% 8.99% Silo Pharma -6,726.39% -88.40% -70.03%

Do analysts rate SILO or AS?

Amer Sports has a consensus target price of $48.19, indicating a potential upside of 34.23%. Given Amer Sports' stronger consensus rating and higher possible upside, analysts clearly believe Amer Sports is more favorable than Silo Pharma. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Silo Pharma 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Amer Sports 0 Sell rating(s) 2 Hold rating(s) 14 Buy rating(s) 2 Strong Buy rating(s) 3.00

Which has better valuation and earnings, SILO or AS?

Amer Sports has higher revenue and earnings than Silo Pharma. Silo Pharma is trading at a lower price-to-earnings ratio than Amer Sports, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Silo Pharma $72.10K 82.96 -$4.23M -$6.45 N/A Amer Sports $6.57B 3.03 $427.40M $0.80 44.88

Is SILO or AS more profitable?

Amer Sports has a net margin of 6.50% compared to Silo Pharma's net margin of -6,726.39%. Amer Sports' return on equity of 10.29% beat Silo Pharma's return on equity. Company Net Margins Return on Equity Return on Assets Silo Pharma -6,726.39% -88.40% -70.03% Amer Sports 6.50% 10.29% 6.30%

Do analysts prefer SILO or LULU?

lululemon athletica has a consensus price target of $154.26, suggesting a potential upside of 32.74%. Given lululemon athletica's stronger consensus rating and higher possible upside, analysts plainly believe lululemon athletica is more favorable than Silo Pharma. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Silo Pharma 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 lululemon athletica 4 Sell rating(s) 27 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 1.97

Silo Pharma (SILO) Competitors

$6.33 -0.30 (-4.52%)

Closing price 04:00 PM Eastern

Extended Trading

$6.28 -0.05 (-0.87%)

As of 05:27 PM Eastern

Compare

SILO vs. PMNT, EVKG, ONON, AS, and LULU

Should you buy Silo Pharma stock or one of its competitors? MarketBeat compares Silo Pharma with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Silo Pharma include Perfect Moment (PMNT), Ever-Glory International Group (EVKG), ON (ONON), Amer Sports (AS), and lululemon athletica (LULU). These companies are all part of the "apparel" industry.

How does Silo Pharma compare to Perfect Moment?

Perfect Moment (NASDAQ:PMNT) and Silo Pharma (NASDAQ:SILO) are both small-cap apparel companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, dividends, risk, valuation, profitability, analyst recommendations and media sentiment.

Perfect Moment has a net margin of -67.38% compared to Silo Pharma's net margin of -6,726.39%. Silo Pharma's return on equity of -88.40% beat Perfect Moment's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Perfect Moment	-67.38%	-513.83%	-119.38%
Silo Pharma	-6,726.39%	-88.40%	-70.03%

In the previous week, Perfect Moment and Perfect Moment both had 2 articles in the media. Silo Pharma's average media sentiment score of 1.43 beat Perfect Moment's score of 0.00 indicating that Silo Pharma is being referred to more favorably in the news media.

Company	Overall Sentiment
Perfect Moment	Neutral
Silo Pharma	Positive

23.0% of Perfect Moment shares are owned by institutional investors. Comparatively, 5.6% of Silo Pharma shares are owned by institutional investors. 22.2% of Perfect Moment shares are owned by insiders. Comparatively, 2.2% of Silo Pharma shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Perfect Moment has a beta of -1.91, suggesting that its share price is 291% less volatile than the broader market. Comparatively, Silo Pharma has a beta of 0.63, suggesting that its share price is 37% less volatile than the broader market.

Perfect Moment presently has a consensus target price of $1.50, indicating a potential upside of 757.14%. Given Perfect Moment's stronger consensus rating and higher possible upside, equities research analysts clearly believe Perfect Moment is more favorable than Silo Pharma.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Perfect Moment	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Silo Pharma	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Silo Pharma has lower revenue, but higher earnings than Perfect Moment. Silo Pharma is trading at a lower price-to-earnings ratio than Perfect Moment, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Perfect Moment	$22.93M	0.36	-$8.72M	-$0.72	N/A
Silo Pharma	$72.10K	82.96	-$4.23M	-$6.45	N/A

Summary

Perfect Moment beats Silo Pharma on 9 of the 15 factors compared between the two stocks.

How does Silo Pharma compare to Ever-Glory International Group?

Ever-Glory International Group (NASDAQ:EVKG) and Silo Pharma (NASDAQ:SILO) are both small-cap apparel companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, risk, media sentiment, valuation, earnings, analyst recommendations, profitability and dividends.

5.6% of Silo Pharma shares are owned by institutional investors. 35.5% of Ever-Glory International Group shares are owned by insiders. Comparatively, 2.2% of Silo Pharma shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Ever-Glory International Group has a net margin of 0.00% compared to Silo Pharma's net margin of -6,726.39%. Ever-Glory International Group's return on equity of 0.00% beat Silo Pharma's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Ever-Glory International Group	N/A	N/A	N/A
Silo Pharma	-6,726.39%	-88.40%	-70.03%

Ever-Glory International Group has higher earnings, but lower revenue than Silo Pharma.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ever-Glory International Group	N/A	N/A	N/A	N/A	N/A
Silo Pharma	$72.10K	82.96	-$4.23M	-$6.45	N/A

Ever-Glory International Group has a beta of 5.06, suggesting that its share price is 406% more volatile than the broader market. Comparatively, Silo Pharma has a beta of 0.63, suggesting that its share price is 37% less volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ever-Glory International Group	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Silo Pharma	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Silo Pharma had 2 more articles in the media than Ever-Glory International Group. MarketBeat recorded 2 mentions for Silo Pharma and 0 mentions for Ever-Glory International Group. Silo Pharma's average media sentiment score of 1.43 beat Ever-Glory International Group's score of 0.00 indicating that Silo Pharma is being referred to more favorably in the news media.

Company	Overall Sentiment
Ever-Glory International Group	Neutral
Silo Pharma	Positive

Summary

Ever-Glory International Group beats Silo Pharma on 6 of the 11 factors compared between the two stocks.

How does Silo Pharma compare to ON?

ON (NYSE:ONON) and Silo Pharma (NASDAQ:SILO) are both apparel companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, media sentiment, analyst recommendations, earnings, risk, institutional ownership, profitability and dividends.

ON has a beta of 2.1, indicating that its stock price is 110% more volatile than the broader market. Comparatively, Silo Pharma has a beta of 0.63, indicating that its stock price is 37% less volatile than the broader market.

ON has higher revenue and earnings than Silo Pharma. Silo Pharma is trading at a lower price-to-earnings ratio than ON, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ON	$3.64B	6.78	$245.87M	$0.93	41.57
Silo Pharma	$72.10K	82.96	-$4.23M	-$6.45	N/A

ON has a net margin of 7.92% compared to Silo Pharma's net margin of -6,726.39%. ON's return on equity of 15.72% beat Silo Pharma's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ON	7.92%	15.72%	8.99%
Silo Pharma	-6,726.39%	-88.40%	-70.03%

36.4% of ON shares are held by institutional investors. Comparatively, 5.6% of Silo Pharma shares are held by institutional investors. 2.2% of Silo Pharma shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

ON presently has a consensus target price of $55.05, indicating a potential upside of 42.39%. Given ON's stronger consensus rating and higher possible upside, equities research analysts plainly believe ON is more favorable than Silo Pharma.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ON	1 Sell rating(s)	4 Hold rating(s)	15 Buy rating(s)	2 Strong Buy rating(s)	2.82
Silo Pharma	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, ON had 18 more articles in the media than Silo Pharma. MarketBeat recorded 20 mentions for ON and 2 mentions for Silo Pharma. Silo Pharma's average media sentiment score of 1.43 beat ON's score of 1.12 indicating that Silo Pharma is being referred to more favorably in the news media.

Company	Overall Sentiment
ON	Positive
Silo Pharma	Positive

Summary

ON beats Silo Pharma on 14 of the 17 factors compared between the two stocks.

How does Silo Pharma compare to Amer Sports?

Silo Pharma (NASDAQ:SILO) and Amer Sports (NYSE:AS) are both apparel companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, media sentiment, valuation, earnings, analyst recommendations, dividends, institutional ownership and risk.

5.6% of Silo Pharma shares are owned by institutional investors. Comparatively, 40.3% of Amer Sports shares are owned by institutional investors. 2.2% of Silo Pharma shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Silo Pharma has a beta of 0.63, suggesting that its share price is 37% less volatile than the broader market. Comparatively, Amer Sports has a beta of 2.05, suggesting that its share price is 105% more volatile than the broader market.

Amer Sports has a net margin of 6.50% compared to Silo Pharma's net margin of -6,726.39%. Amer Sports' return on equity of 10.29% beat Silo Pharma's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Silo Pharma	-6,726.39%	-88.40%	-70.03%
Amer Sports	6.50%	10.29%	6.30%

Amer Sports has higher revenue and earnings than Silo Pharma. Silo Pharma is trading at a lower price-to-earnings ratio than Amer Sports, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Silo Pharma	$72.10K	82.96	-$4.23M	-$6.45	N/A
Amer Sports	$6.57B	3.03	$427.40M	$0.80	44.88

Amer Sports has a consensus target price of $48.19, indicating a potential upside of 34.23%. Given Amer Sports' stronger consensus rating and higher possible upside, analysts clearly believe Amer Sports is more favorable than Silo Pharma.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Silo Pharma	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Amer Sports	0 Sell rating(s)	2 Hold rating(s)	14 Buy rating(s)	2 Strong Buy rating(s)	3.00

In the previous week, Amer Sports had 4 more articles in the media than Silo Pharma. MarketBeat recorded 6 mentions for Amer Sports and 2 mentions for Silo Pharma. Amer Sports' average media sentiment score of 1.45 beat Silo Pharma's score of 1.43 indicating that Amer Sports is being referred to more favorably in the news media.

Company	Overall Sentiment
Silo Pharma	Positive
Amer Sports	Positive

Summary

Amer Sports beats Silo Pharma on 15 of the 17 factors compared between the two stocks.

How does Silo Pharma compare to lululemon athletica?

Silo Pharma (NASDAQ:SILO) and lululemon athletica (NASDAQ:LULU) are both apparel companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, institutional ownership, dividends, risk, earnings, media sentiment, analyst recommendations and profitability.

Silo Pharma has a beta of 0.63, indicating that its stock price is 37% less volatile than the broader market. Comparatively, lululemon athletica has a beta of 0.88, indicating that its stock price is 12% less volatile than the broader market.

lululemon athletica has higher revenue and earnings than Silo Pharma. Silo Pharma is trading at a lower price-to-earnings ratio than lululemon athletica, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Silo Pharma	$72.10K	82.96	-$4.23M	-$6.45	N/A
lululemon athletica	$11.10B	1.24	$1.58B	$12.39	9.38

5.6% of Silo Pharma shares are held by institutional investors. Comparatively, 85.2% of lululemon athletica shares are held by institutional investors. 2.2% of Silo Pharma shares are held by insiders. Comparatively, 0.5% of lululemon athletica shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

lululemon athletica has a net margin of 13.03% compared to Silo Pharma's net margin of -6,726.39%. lululemon athletica's return on equity of 31.26% beat Silo Pharma's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Silo Pharma	-6,726.39%	-88.40%	-70.03%
lululemon athletica	13.03%	31.26%	17.98%

In the previous week, lululemon athletica had 34 more articles in the media than Silo Pharma. MarketBeat recorded 36 mentions for lululemon athletica and 2 mentions for Silo Pharma. Silo Pharma's average media sentiment score of 1.43 beat lululemon athletica's score of 0.53 indicating that Silo Pharma is being referred to more favorably in the media.

Company	Overall Sentiment
Silo Pharma	Positive
lululemon athletica	Positive

lululemon athletica has a consensus price target of $154.26, suggesting a potential upside of 32.74%. Given lululemon athletica's stronger consensus rating and higher possible upside, analysts plainly believe lululemon athletica is more favorable than Silo Pharma.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Silo Pharma	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
lululemon athletica	4 Sell rating(s)	27 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	1.97

Summary

lululemon athletica beats Silo Pharma on 14 of the 17 factors compared between the two stocks.

Get Silo Pharma News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SILO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SILO vs. The Competition

Export

Metric	Silo Pharma	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$5.98M	$3.39B	$6.48B	$12.35B
Dividend Yield	N/A	2.25%	2.67%	5.66%
P/E Ratio	-0.98	20.09	23.97	24.58
Price / Sales	82.96	319.77	536.03	167.29
Price / Cash	N/A	53.61	27.48	37.92
Price / Book	0.89	8.08	10.47	6.78
Net Income	-$4.23M	$23.89M	$3.56B	$337.32M
7 Day Performance	1.12%	2.25%	0.87%	1.96%
1 Month Performance	5.42%	0.21%	1.82%	3.81%
1 Year Performance	-28.16%	45.16%	25.66%	32.19%

Silo Pharma Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SILO Silo Pharma	0.9233 of 5 stars	$6.33 -4.5%	N/A	-24.8%	$5.98M	$72.10K	N/A	2	Positive News Short Interest Decrease
PMNT Perfect Moment	1.3627 of 5 stars	$0.23 +2.3%	$1.50 +549.4%	-55.4%	$10.83M	$22.93M	N/A	31
EVKG Ever-Glory International Group	N/A	$0.00 flat	N/A	-71.4%	$3K	N/A	N/A	4,300
ONON ON	4.9466 of 5 stars	$37.55 -2.0%	$55.05 +46.6%	-26.3%	$24.45B	$3.64B	40.38	3,963	Positive News Gap Up
AS Amer Sports	4.4754 of 5 stars	$34.42 -2.8%	$48.19 +40.0%	-2.1%	$19.61B	$6.57B	43.02	15,400	Positive News Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:SILO) was last updated on 6/15/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Silo Pharma (SILO) Competitors

SILO vs. PMNT, EVKG, ONON, AS, and LULU

How does Silo Pharma compare to Perfect Moment?

Summary

How does Silo Pharma compare to Ever-Glory International Group?

Summary

How does Silo Pharma compare to ON?

Summary

How does Silo Pharma compare to Amer Sports?

Summary

How does Silo Pharma compare to lululemon athletica?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SILO vs. The Competition

Silo Pharma Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Silo Pharma (SILO) Competitors

SILO vs. PMNT, EVKG, ONON, AS, and LULU

How does Silo Pharma compare to Perfect Moment?

Is PMNT or SILO more profitable?

Does the media favor PMNT or SILO?

Do institutionals & insiders have more ownership in PMNT or SILO?

Which has more risk & volatility, PMNT or SILO?

Do analysts prefer PMNT or SILO?

Which has better earnings & valuation, PMNT or SILO?

Summary

How does Silo Pharma compare to Ever-Glory International Group?

Do insiders and institutionals hold more shares of EVKG or SILO?

Is EVKG or SILO more profitable?

Which has preferable valuation and earnings, EVKG or SILO?

Which has more risk & volatility, EVKG or SILO?

Do analysts rate EVKG or SILO?

Does the media prefer EVKG or SILO?

Summary

How does Silo Pharma compare to ON?

Which has more risk & volatility, ONON or SILO?

Which has better earnings & valuation, ONON or SILO?

Is ONON or SILO more profitable?

Do institutionals and insiders hold more shares of ONON or SILO?

Do analysts prefer ONON or SILO?

Does the media prefer ONON or SILO?

Summary

How does Silo Pharma compare to Amer Sports?

Do insiders & institutionals believe in SILO or AS?

Which has more risk and volatility, SILO or AS?

Is SILO or AS more profitable?

Which has better valuation and earnings, SILO or AS?

Do analysts rate SILO or AS?

Does the media prefer SILO or AS?

Summary

How does Silo Pharma compare to lululemon athletica?

Which has more volatility and risk, SILO or LULU?

Which has preferable earnings & valuation, SILO or LULU?

Do insiders & institutionals believe in SILO or LULU?

Is SILO or LULU more profitable?

Does the media prefer SILO or LULU?

Do analysts prefer SILO or LULU?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SILO vs. The Competition

Silo Pharma Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools